A platform helping drug discovery companies take a novel concept to makeable compound has been validated in three academic papers. Chemify says its Chemputation platform, which integrates AI- and ML-driven molecular discovery and automated robotic synthesis, has been validated as a new paradigm for how small molecule-drugs and materials are discovered, designed and manufactured. … Read More
Scottish tech company Chemify has received $1.6 million from the Gates Foundation to continue the discovery of small molecules for tuberculosis (TB). Building on a successful collaboration with Lgenia, the expanded project will leverage Chemify’s automated platform to design and synthesise new drug leads, aiming to address one of the world’s most… Read More
Chemify has unveiled its first Chemifarm—a fully automated chemistry facility regarded as the world’s most advanced laboratory for molecular design and synthesis. Situated in Glasgow’s Maryhill district, the site unites Chemify’s AI-driven molecular-design engine with industrial-scale robotic synthesis, compressing the journey from concept to compound and accelerating… Read More
